HomeHealthcare & Life SciencesBiotechnology Microbial Transglutaminase Market

Australia Microbial Transglutaminase Market Size & Outlook, 2025-2033


Australia Microbial Transglutaminase Market Insights

  • Reed Intelligence analysis indicates that the Australia Microbial Transglutaminase Market size, valued at USD 1.97 Million in 2024, is expected to expand to USD 4.6 Million by 2033.
  • The Australia market is forecasted to expand at a CAGR of 9.97% spanning 2026–2033.
  • Streptomyces Mobaraense held the leading position among By Source segments in 2024, based on market size.
  • Others is projected to post the fastest growth rate, sustaining its position as the most attractive By Source segment during the forecast horizon.

Other Key Findings


  • In 2024, Australia represented 1.44% of the overall global Microbial Transglutaminase Market size.
  • United States is projected to lead the global Microbial Transglutaminase Market size by 2033.
  • Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2033.
  • China is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 36.3 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 1.97 Million
Market Size In 2033 USD 4.6 Million
Largest segment Streptomyces Mobaraense
Units Revenue in USD Million
CAGR 9.97% (2025-2033)
Segmnetation Covered
By Source
  1. Streptomyces Mobaraense
  2. Streptoverticillium Griseocarneum
  3. Streptoverticillium Hygroscopicus
  4. Others
By Form
  1. Powder
  2. Liquid
By End-Use Industry
  1. Food & Beverage
  2. Pharmaceuticals
  3. Cosmetics
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports